LEO Pharma and the National Association of Health Informants (ANIS) celebrated the II Dermatology News Cyclewhich brought together experts, patient associations and broadcasters to address the challenges of skin diseases, such as chronic hand eczema and atopic dermatitis. The event highlighted the impact of misinformation, a growing problem on social media and how it affects the clinical, emotional and social management of those suffering from these pathologies.
The meeting began with an interview with the famous Pharmacist Fernándezwho highlighted that hoaxes and myths about skin diseases, such as “atopic dermatitis is hereditary” or “chronic hand eczema is contagious”, generate confusion and negatively affect patient confidence. “The impact of misinformation on the health of patients with skin diseases are huge. Not only does this affect the social perception of these pathologies, but it can also lead people to opt for inappropriate treatments or abandon recommended medical follow-up,” said Farmacéutico Fernández. He also stressed that the lack of precise information can worsen the emotional consequences of skin diseases, which are usually accompanied by problems such as anxiety, stress and low self-esteem.
From his experience in the pharmaceutical field, he highlighted the key role of pharmacies as accessible and reliable points of contact for patients. “Pharmacies are in a privileged position to detect patient doubts, offer them reliable information and redirect them to the dermatologistwho is the expert in the clinical field. In addition, we need to work more actively to educate patients, helping them identify truthful information in an environment saturated with hoaxes,” he added.
The expert concluded by encouraging health professionals and broadcasters to join forces to combat misinformation on social networks and other media. “Pharmacies are not just spaces drug distribution; They are also health education centers that can make a big difference in the lives of those living with chronic conditions such as chronic hand eczema and atopic dermatitis,” he said.
Misinformation
The day continued with a round table where chronic hand eczema was discussed in depth. At the table, hosted by Alipio Gutiérrez, vice-president of ANIS, the Dr. Pedro Herranz, head of the Department of Dermatology at the University Hospital of La Paz and Jaime Llaneza, president of the Association of People Affected by Atopic Dermatitis (AADA).
During the round table, key data on this pathology were presented. Chronic hand eczema is a multifactorial inflammatory disease that causes severe symptoms, such as itching, severe pain, and deep crackswith a strong functional, professional and psychological impact.
He Dr Pedro Herranz explains that “chronic hand eczema in its most severe form is a skin pathology that requires multidisciplinary treatment. Patients, depending on their level of involvement, may need help from dermatologists, psychologists, therapists or other professionals. “A comprehensive approach and patient education are essential to controlling symptoms and improving quality of life. » He also highlighted the professional and emotional impact of chronic hand eczema, emphasizing that “Symptoms such as itching and pain have a high psychological burden, functional and professional. The lack of control over the disease and the unpredictability of outbreaks generate frustration, stress and, sometimes, mood disorders, such as depression and anxiety.
For his part, Jaime Llaneza highlighted the fundamental role of associations in supporting patients. “Associations not only offer emotional support, but also function as an essential filter alongside health professionals to provide quality information and clear answers to the doubts of patients with skin pathologies,” he said.
He also wanted to share a thought on how accurate information can make a big difference in patients’ daily lives. “The commitment and involvement of everyone is necessary to fight against disinformation andhoaxes on social networks and the internet. Fortunately, we have great professionals and associations working on it,” he noted. In this sense, Llaneza emphasized that “it is crucial to have quality information and training on our pathologies to be able to recognize and treat them appropriately. “This not only improves skin care, but also promotes earlier and more effective care.”
The day ended with a collective commitment to work on awareness and education on dermatological diseases. Speakers and participants highlighted the need to generate reliable and accessible content that can counter the impact of disinformation and improve the quality of life of those affected. This event not only reflected the commitment of LEO Pharma and ANIS with medical dermatology, but marked a decisive step towards a future in which precise knowledge is the key tool for the well-being of patients.
